CN1778379A - Compound pearl grass oral liquid - Google Patents
Compound pearl grass oral liquid Download PDFInfo
- Publication number
- CN1778379A CN1778379A CNA2004100972601A CN200410097260A CN1778379A CN 1778379 A CN1778379 A CN 1778379A CN A2004100972601 A CNA2004100972601 A CN A2004100972601A CN 200410097260 A CN200410097260 A CN 200410097260A CN 1778379 A CN1778379 A CN 1778379A
- Authority
- CN
- China
- Prior art keywords
- herba
- oral liquid
- compound pearl
- pearl grass
- grass oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of oral liquid for treating the diseases of three Yang meridians is prepared from 11 Chinese-medicinal materials including common leafflower herb, river snail, loach, ganoderma, etc.
Description
The present invention is a kind of treatment acute or chronic hepatitis B, falls that big and small three Yang is effective, short treating period, the compound Chinese herb fast, few side effects that comes into force, and belongs to the new drug invention field.
Past has treatment to fall the medicine of big and small three Yang, as lamivudine, and interferon, left-handed rice azoles etc., weak curative effect, the course of treatment is long, side effect is big, effect is undesirable.
The present invention seeks to provides the Chinese medicine formula of a kind of good effect, short treating period, few side effects, taking convenience in order to overcome above-mentioned shortcoming.
This side is made up of following each medicine.
1, Margarita leather: function with cure mainly: calming liver and clearing heat, promoting diuresis to remove toxic substance, control enteritis and dysentery, infectious hepatitis, oedema due to nephritis, urinary tract infection, infantile malnutrition, fire class nebula, aphtha head sore, innominate toxic swelling.
Usage and consumption: take, fry in shallow oil soup 1.5 grams-50 grams (bright person 50-100 gram) orally, twice on the one.
2, Herba Rabdosiae Lophanthoidis: function with cure mainly: clearing away heat-damp and promoting diuresis, cool the blood dissipate blood stasis, control acute hepatitis, dysentery, enteritis.
Usage and consumption: take, fry in shallow oil soup 1.5 grams-50 grams (bright person 60-90 gram) orally, twice on the one.
3, Cipangopaludina chinensis: function with cure mainly: heat clearing away, diuretic, control hot urinary obstruction, jaundice, beriberi.
Dosage: 2-3, twice on the one.
4, Herba Abri: function with cure mainly: heat-clearing and toxic substances removing, soothing liver-QI eliminating stagnation, the subcutaneous ulcer of harnessing the Yellow River hepatitis etc.
Usage and consumption: take, fry in shallow oil soup 10 grams-15 grams orally, twice on the one.
5, Stigma Maydis: diuresis, expel the heat-evil, suppressing the hyperactive liver, function of gallbladder promoting, control oedema due to nephritis, icterohepatitis etc.
Usage and consumption: take, fry in shallow oil soup 30 grams-60 grams orally, twice on the one.
6, Herba Euphorbiae Humifusae: function with cure mainly: heat-clearing and toxic substances removing, invigorate blood circulation, hemostasis, dampness removing etc., control enteritis, have blood in stool, jaundice due to damp-heat etc.
Usage and consumption: take, fry in shallow oil soup 3-6 gram orally, twice on the one.
7, ear leather: function with cure mainly: clearing away heat-damp and promoting diuresis, subduing swelling and detoxicating, control infectious hepatitis etc.
Usage and consumption: take, fry in shallow oil soup 5-10 gram orally, twice on the one.
8, Misgurni anguillicaudati: function with cure mainly: acute, subacute, chronic persistent hepatitis.
Usage and consumption: 15 grams for oral administration, twice on the one.
9, Herba Elephantopi scaberis: function with cure mainly: removing heat from blood, heat clearing away, function of gallbladder promoting, detoxify, harness the Yellow River subcutaneous ulcer, beriberi etc.
Usage and consumption: 10-15 gram for oral administration, twice on the one.
10, Folium cratoxyli ligustrini: function with cure mainly: detumescence, detoxification, control belly pain diarrhoea, jaundice etc.
Usage and consumption: 1-10 gram for oral administration, twice on the one.
11, FUFANG LINGZHI KELI: function with cure mainly: have the liver protecting to reduce glutamate pyruvate transaminase and jaundice eliminating effect, be used for acute icterohepatitisshock, diseases such as chronic persistent hepatitis, chronic hepatitis B, individual event Glutamate pyruvate transaminase rises.
Usage and consumption: 5 grams for oral administration, twice on the one.The 2-3 month is a course of treatment.
More than 10 kinds of medical herbs make by requirement by the oral liquid formulations general rule.
That this product is formed is simple, reasonable in design, taking convenience, good effect, cost are low, short treating period, few side effects, makes things convenient for the patient.
Claims (4)
1, a kind of compound pearl grass oral liquid comprises Herba Phyllanthi Urinariae, Herba Rabdosiae Lophanthoidis, Cipangopaludina chinensis, Herba Abri, Misgurni anguillicaudati, Stigma Maydis, Herba Hyperici Japonici, Herba Euphorbiae Humifusae, Herba Elephantopi scaberis, Folium cratoxyli ligustrini, FUFANG LINGZHI KELI.
2,, it is characterized in that left-handed rice azoles, alternative Misgurni anguillicaudati according to claims 1 described compound pearl grass oral liquid.
3,, it is characterized in that interferon, calf thymus peptide also can replace Cipangopaludina chinensis, Stigma Maydis according to claims 1 described compound pearl grass oral liquid.
4,, it is characterized in that the also alternative Herba Elephantopi scaberis of lamivudine, Herba Euphorbiae Humifusae according to claims 1 described compound pearl grass oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2004100972601A CN1778379A (en) | 2004-11-19 | 2004-11-19 | Compound pearl grass oral liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2004100972601A CN1778379A (en) | 2004-11-19 | 2004-11-19 | Compound pearl grass oral liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1778379A true CN1778379A (en) | 2006-05-31 |
Family
ID=36768916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100972601A Pending CN1778379A (en) | 2004-11-19 | 2004-11-19 | Compound pearl grass oral liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1778379A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229327B (en) * | 2008-01-25 | 2011-02-16 | 刘信飞 | Medicine for treating chronic hepatitis b and preparing method thereof |
CN102362669A (en) * | 2011-10-20 | 2012-02-29 | 董燕花 | Rabdosiea Serrae Hara Guiling gel |
CN103205339A (en) * | 2013-03-16 | 2013-07-17 | 陆开云 | Mugua Huangniucha rice wine and making method thereof |
CN104188030A (en) * | 2014-07-24 | 2014-12-10 | 刘山玉 | Health drink |
-
2004
- 2004-11-19 CN CNA2004100972601A patent/CN1778379A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229327B (en) * | 2008-01-25 | 2011-02-16 | 刘信飞 | Medicine for treating chronic hepatitis b and preparing method thereof |
CN102362669A (en) * | 2011-10-20 | 2012-02-29 | 董燕花 | Rabdosiea Serrae Hara Guiling gel |
CN103205339A (en) * | 2013-03-16 | 2013-07-17 | 陆开云 | Mugua Huangniucha rice wine and making method thereof |
CN103205339B (en) * | 2013-03-16 | 2014-03-26 | 陆开云 | Mugua Huangniucha rice wine and making method thereof |
CN104188030A (en) * | 2014-07-24 | 2014-12-10 | 刘山玉 | Health drink |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102357146B (en) | Traditional Chinese medicine for treating beriberi | |
CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
CN1778379A (en) | Compound pearl grass oral liquid | |
CN1720965A (en) | Chinese medicinal composition for treating acute icterohepatitis | |
CN103977106B (en) | A kind of Chinese medicine preparation for the treatment of nephrotic syndrome and preparation method thereof | |
CN100546618C (en) | The psoriatic Chinese medicine preparation of a kind of treatment | |
CN100342894C (en) | A Chinese medicine for treating liver disease | |
CN100340270C (en) | Medicine for treating postpartum pathogenic-wind affection | |
CN109700976B (en) | Qie and zedoary liver-protecting paste | |
CN1682814A (en) | Medicine for treating hepatitis B and its preparing process | |
CN100518800C (en) | Medicinal composition for treating hepatitis B | |
CN1050045C (en) | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus | |
KR20040049349A (en) | Composition for Promotion of Fatigue Recovery And Process for Preparation Thereof, Medicine of Fatigue Recovery Using The Same | |
CN1943766A (en) | A Chinese traditional medicinal preparation for treatment of psoriasis | |
CN1210005A (en) | Medicine for necrosis of femoral head | |
CN1055014C (en) | Medicine powder for curing hepatitis B | |
CN1488372A (en) | Chinese medicine formual for treating heptitis | |
CN103989767B (en) | A kind of treat verruca plana pharmaceutical composition and preparation technology and application | |
CN1041992C (en) | Preparation technology of cold resistant panacla tablet | |
CN100506272C (en) | Psoriasis treating Chinese medicine preparation | |
CN100546623C (en) | The psoriatic Chinese medicine preparation of a kind of treatment | |
CN1052886C (en) | Chinese drug powder for curing hepatitis B and its preparing method | |
CN101028352A (en) | Chinese-medicinal preparation for treating ischiodynia | |
CN101108220A (en) | Medicine for treating hepatitis | |
CN1054043C (en) | Pharmaceutical composition for treating typhoid fever |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |